Naxitamab-Based Chemoimmunotherapy for Resistant High-Risk Neuroblastoma: Preliminary Results of Hits Treatment

Mora, J; Castaneda, A; Flores, M; Gorostegui, M; Simao, M; Santa-Maria, V; Garraus, M; Chamizo, A; Lazaro, JJ

PEDIATRIC BLOOD & CANCER, 2020; 67 (): S32